Background: Evidence on the efficacy and safety of anticoagulation in preventing stroke and thromboembolic events in people with thyrotoxic atrial fibrillation is scarce.
Objective: We evaluated the efficacy and safety of anticoagulation in people with thyrotoxic atrial fibrillation.
Methods: Our study protocol was published in the International Prospective Register of Systematic Reviews (registration no.